Stock A334970 PRESTIGE BIOLOGICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Prestige Biologics Co., Ltd.

Equities

A334970

KR7334970001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 03/07/2024 BST 		5-day change 1st Jan Change
4,250 KRW -0.93% Intraday chart for Prestige Biologics Co., Ltd. +5.85% -3.41%
2023 Prestige Biologics Co., Ltd. announced that it has received KRW 45.5 billion in funding from Octava Fund Limited CI
2023 Prestige Biologics Co., Ltd. announced that it expects to receive KRW 45.5 billion in funding from Octava Fund Limited CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PRESTIGE BIOLOGICS CO., LTD.
Biopharmaceuticals
-0.93%+5.85%-3.41%-2.52% - 189M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. A334970 Stock
  4. Charts Prestige Biologics Co., Ltd.
  5. Comparison Chart